AstraZeneca PLC (AZN) Meet the Management at ESMO 2024 Conference (Transcript)
AstraZeneca PLC (NASDAQ:AZN ) Meet the Management at ESMO 2024 Conference September 16, 2024 2:00 PM ET Company Participants Pascal Soriot - Chief Executive Officer Susan Galbraith - EVP, Oncology ...
AstraZeneca Stock Downgraded on Drug Trial Results
Biopharmaceutical stock AstraZeneca PLC (NASDAQ:AZN) is 1.3% lower before the open, after a bear note from Deutsche Bank.
AstraZeneca Faces Setback From Lung Cancer Drug's Disappointing Trial Results
A Phase 3 trial found AstraZeneca's (AZN) experimental lung cancer drug datopotamab deruxtecan (Dato-DXd) did not significantly improve patients' overall survival rates.
SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing
The companies commit to bring cutting-edge liquid biopsy testing to 20 institutions globally over the next 12 months BOSTON and ROLLE, Switzerland , Sept. 10, 2024 /PRNewswire/ -- SOPHiA GENETICS (...
AstraZeneca Employees Detained in China: CEO Says Firm Is Working With Authorities
AstraZeneca CEO Pascal Soriot discusses China's detainment of five current and former employees for questioning about potential illegal activities. "We are working very closely with the authorities...
AstraZeneca shares fall 5% on disappointing lung cancer drug trial results
AstraZeneca shares fell more than 5% Tuesday morning, the biggest one-day drop in seven months, after the British pharmaceutical giant announced disappointing lung cancer drug trial results.
3 Market-Beating Stocks to Buy for Less Than $100
AstraZeneca's robust pipeline and plentiful growth opportunities make it one of the best healthcare stocks to buy. Chewy is coming off a solid quarter, and there's still more growth ahead in the pe...
AstraZeneca Employees Held in China for Drug-Import, Data Privacy Investigations
Five current and former AstraZeneca (AZN) employees have been detained by police in China in connection with alleged violations of data privacy laws and for importing an unapproved cancer drug, acc...
AstraZeneca confirms five employees held by China police
AstraZeneca PLC (LSE:AZN) has confirmed that five current and former employees in China are being held by police for questioning. The individuals, all Chinese nationals, worked in the company's onc...
China detains AstraZeneca staff in data, drug-import probes, Bloomberg News reports
The police in China have detained five current and former employees of AstraZeneca for questioning about potential illegal activities, Bloomberg News reported on Thursday, citing people familiar wi...
Nvidia whacked for $270bn as economic, AI concerns mount
Nvidia Corp's volatile nature was on full display when its share price fell nearly 10% before the closing bell on Tuesday. It meant a record $270 billion was stripped from the artificial intelligen...
AstraZeneca (AZN) Denies Rumors About UK Facility Relocation
Per third-party reports, AstraZeneca (AZN) has refuted rumors about considering a change in the relocation of a vaccine manufacturing plant from the U.K. to the United States.
Rumours of AstraZeneca relocating vaccine ops to US ‘untrue'
British biotech giant AstraZeneca PLC (LSE:AZN) has rebuffed claims that it is moving its vaccine operations to the US. A Financial Times report suggested that AstraZeneca could relocate its vaccin...
FDA Expands AstraZeneca's (AZN) Imfinzi Label in Lung Cancer
This approval is based on late-stage study data, which shows that treatment with AstraZeneca's (AZN) Imfinzi reduced the risk of recurrence by 32% in certain non-small cell lung cancer patients.
AstraZeneca receives another US approval for cancer drug Imfinzi
AstraZeneca PLC's (LSE:AZN) blockbuster immunotherapy cancer drug Imfinzi (durvalumab) has received another approval in the US. In combination with chemotherapy, patients suffering resectable early...
Related Companies